DNA typing for HLA-DPB1*02 and -DPB1*04 in multiple sclerosis and juvenile rheumatoid arthritis

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

DNA typing for HLA-DPB1*02 and -DPB1*04 in multiple sclerosis and juvenile rheumatoid arthritis. / Fugger, L; Ryder, L P; Morling, N; Ødum, Niels; Friis, J; Pedersen, F K; Heilmann, C; Sandberg-Wollheim, M; Svejgaard, A.

In: Immunogenetics, Vol. 32, No. 3, 1990, p. 150-6.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Fugger, L, Ryder, LP, Morling, N, Ødum, N, Friis, J, Pedersen, FK, Heilmann, C, Sandberg-Wollheim, M & Svejgaard, A 1990, 'DNA typing for HLA-DPB1*02 and -DPB1*04 in multiple sclerosis and juvenile rheumatoid arthritis', Immunogenetics, vol. 32, no. 3, pp. 150-6.

APA

Fugger, L., Ryder, L. P., Morling, N., Ødum, N., Friis, J., Pedersen, F. K., Heilmann, C., Sandberg-Wollheim, M., & Svejgaard, A. (1990). DNA typing for HLA-DPB1*02 and -DPB1*04 in multiple sclerosis and juvenile rheumatoid arthritis. Immunogenetics, 32(3), 150-6.

Vancouver

Fugger L, Ryder LP, Morling N, Ødum N, Friis J, Pedersen FK et al. DNA typing for HLA-DPB1*02 and -DPB1*04 in multiple sclerosis and juvenile rheumatoid arthritis. Immunogenetics. 1990;32(3):150-6.

Author

Fugger, L ; Ryder, L P ; Morling, N ; Ødum, Niels ; Friis, J ; Pedersen, F K ; Heilmann, C ; Sandberg-Wollheim, M ; Svejgaard, A. / DNA typing for HLA-DPB1*02 and -DPB1*04 in multiple sclerosis and juvenile rheumatoid arthritis. In: Immunogenetics. 1990 ; Vol. 32, No. 3. pp. 150-6.

Bibtex

@article{f915dd50fd9f11ddb219000ea68e967b,
title = "DNA typing for HLA-DPB1*02 and -DPB1*04 in multiple sclerosis and juvenile rheumatoid arthritis",
abstract = "DP gene typing using in vitro DNA amplification combined with sequence-specific oligonucleotide probes (SSOP) has recently been reported. The amplification step may be specific for the HLA-DPB locus, or it may be specific for one or a group of HLA-DPB alleles, thus increasing the discriminatory power of the system. We report the combined use of group-specific DNA in vitro amplification followed by SSOP in typing for DPB1*02 and DPB1*04 variants. The method was used to type for these variants in 96 randomly selected, healthy Danes, in 37 patients with pauciarticular juvenile rheumatoid arthritis (PJRA), and in 38 patients with multiple sclerosis (MS). Increased frequencies of the cellularly defined HLA-DPw2 in PJRA and of HLA-DPw4 in MS have previously been reported. In the patient groups, the frequencies of the DPB1*02 and DPB1*04 variants did not differ significantly from those expected based on the cellularly defined HLA-DP types of the patients and the frequencies of the DPB1*02 and DPB1*04 variants among healthy Danes.",
author = "L Fugger and Ryder, {L P} and N Morling and Niels {\O}dum and J Friis and Pedersen, {F K} and C Heilmann and M Sandberg-Wollheim and A Svejgaard",
note = "Keywords: Amino Acid Sequence; Arthritis, Juvenile Rheumatoid; Base Sequence; Gene Amplification; Gene Frequency; HLA-DP Antigens; Humans; Molecular Sequence Data; Multiple Sclerosis; Nucleic Acid Hybridization; Oligonucleotide Probes; Polymerase Chain Reaction; Sequence Homology, Nucleic Acid",
year = "1990",
language = "English",
volume = "32",
pages = "150--6",
journal = "Immunogenetics",
issn = "0093-7711",
publisher = "Springer",
number = "3",

}

RIS

TY - JOUR

T1 - DNA typing for HLA-DPB1*02 and -DPB1*04 in multiple sclerosis and juvenile rheumatoid arthritis

AU - Fugger, L

AU - Ryder, L P

AU - Morling, N

AU - Ødum, Niels

AU - Friis, J

AU - Pedersen, F K

AU - Heilmann, C

AU - Sandberg-Wollheim, M

AU - Svejgaard, A

N1 - Keywords: Amino Acid Sequence; Arthritis, Juvenile Rheumatoid; Base Sequence; Gene Amplification; Gene Frequency; HLA-DP Antigens; Humans; Molecular Sequence Data; Multiple Sclerosis; Nucleic Acid Hybridization; Oligonucleotide Probes; Polymerase Chain Reaction; Sequence Homology, Nucleic Acid

PY - 1990

Y1 - 1990

N2 - DP gene typing using in vitro DNA amplification combined with sequence-specific oligonucleotide probes (SSOP) has recently been reported. The amplification step may be specific for the HLA-DPB locus, or it may be specific for one or a group of HLA-DPB alleles, thus increasing the discriminatory power of the system. We report the combined use of group-specific DNA in vitro amplification followed by SSOP in typing for DPB1*02 and DPB1*04 variants. The method was used to type for these variants in 96 randomly selected, healthy Danes, in 37 patients with pauciarticular juvenile rheumatoid arthritis (PJRA), and in 38 patients with multiple sclerosis (MS). Increased frequencies of the cellularly defined HLA-DPw2 in PJRA and of HLA-DPw4 in MS have previously been reported. In the patient groups, the frequencies of the DPB1*02 and DPB1*04 variants did not differ significantly from those expected based on the cellularly defined HLA-DP types of the patients and the frequencies of the DPB1*02 and DPB1*04 variants among healthy Danes.

AB - DP gene typing using in vitro DNA amplification combined with sequence-specific oligonucleotide probes (SSOP) has recently been reported. The amplification step may be specific for the HLA-DPB locus, or it may be specific for one or a group of HLA-DPB alleles, thus increasing the discriminatory power of the system. We report the combined use of group-specific DNA in vitro amplification followed by SSOP in typing for DPB1*02 and DPB1*04 variants. The method was used to type for these variants in 96 randomly selected, healthy Danes, in 37 patients with pauciarticular juvenile rheumatoid arthritis (PJRA), and in 38 patients with multiple sclerosis (MS). Increased frequencies of the cellularly defined HLA-DPw2 in PJRA and of HLA-DPw4 in MS have previously been reported. In the patient groups, the frequencies of the DPB1*02 and DPB1*04 variants did not differ significantly from those expected based on the cellularly defined HLA-DP types of the patients and the frequencies of the DPB1*02 and DPB1*04 variants among healthy Danes.

M3 - Journal article

C2 - 2228045

VL - 32

SP - 150

EP - 156

JO - Immunogenetics

JF - Immunogenetics

SN - 0093-7711

IS - 3

ER -

ID: 10637287